Twist 1 regulates the expression of PPARγ during hormone-induced 3T3-L1 preadipocyte differentiation: a possible role in obesity and associated diseases.
Abstract
[BACKGROUND] Twist 1 is highly expressed in adipose tissue and has been associated with obesity and related disorders. However, the molecular function of Twist 1 in adipose tissue is unclear. Twist 1 has been implicated in cell lineage determination and differentiation. Therefore, we investigated both the role of Twist 1 in adipocyte precursor mobilization and the relationship of Twist 1 with other molecular determinants of adipocyte differentiation.
[METHODS] We examined Twist 1 mRNA and protein expression in subcutaneous adipose tissues from diet-induced obese C57/BL6 mice and Wistar rats and in obese patients undergoing liposuction or adipose transplant surgeries. Twist 1 expression was measured on days 0, 2, 4, 8, and 12 of 3T3-L1 differentiation in vitro. The role of Twist 1 in adipogenesis was explored using retroviral interference of Twist 1 expression. Adipokine secretion was evaluated using a RayBio® Biotin Label-based Adipokine Array.
[RESULTS] Twist 1 mRNA and protein levels were reduced in diet-induced obese mice and rats and in obese humans. Twist 1 was upregulated during 3T3-L1 preadipocyte differentiation in vitro, beginning from the fourth day of differentiation induction. Retroviral interference of Twist 1 expression did not significantly impair lipid formation; however, retroviral interference induced PPARγ mRNA and protein expression on day 4 of differentiation induction. Adipokine array analyses revealed increased secretion of CXCR4 (19.55-fold), VEGFR1 (92.13-fold), L-21 R (63.55-fold), and IL-12 R beta 1 (59.66-fold) and decreased secretion of VEGFR3 (0.01-fold), TSLP R (0.071-fold), MIP-1 gamma (0.069-fold), TNF RI/TNFRSF1A (0.09-fold), and MFG-E8 (0.06-fold).
[CONCLUSIONS] Twist 1 is a regulator of adipocyte gene expression although it is not likely to regulate differentiation. We identified PPARγ as a potential target of Twist 1 and found variation in the secretion of multiple adipokines, which might indicate a prospective mechanism linking Twist 1 expression with obesity or associated diseases.
[METHODS] We examined Twist 1 mRNA and protein expression in subcutaneous adipose tissues from diet-induced obese C57/BL6 mice and Wistar rats and in obese patients undergoing liposuction or adipose transplant surgeries. Twist 1 expression was measured on days 0, 2, 4, 8, and 12 of 3T3-L1 differentiation in vitro. The role of Twist 1 in adipogenesis was explored using retroviral interference of Twist 1 expression. Adipokine secretion was evaluated using a RayBio® Biotin Label-based Adipokine Array.
[RESULTS] Twist 1 mRNA and protein levels were reduced in diet-induced obese mice and rats and in obese humans. Twist 1 was upregulated during 3T3-L1 preadipocyte differentiation in vitro, beginning from the fourth day of differentiation induction. Retroviral interference of Twist 1 expression did not significantly impair lipid formation; however, retroviral interference induced PPARγ mRNA and protein expression on day 4 of differentiation induction. Adipokine array analyses revealed increased secretion of CXCR4 (19.55-fold), VEGFR1 (92.13-fold), L-21 R (63.55-fold), and IL-12 R beta 1 (59.66-fold) and decreased secretion of VEGFR3 (0.01-fold), TSLP R (0.071-fold), MIP-1 gamma (0.069-fold), TNF RI/TNFRSF1A (0.09-fold), and MFG-E8 (0.06-fold).
[CONCLUSIONS] Twist 1 is a regulator of adipocyte gene expression although it is not likely to regulate differentiation. We identified PPARγ as a potential target of Twist 1 and found variation in the secretion of multiple adipokines, which might indicate a prospective mechanism linking Twist 1 expression with obesity or associated diseases.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 시술 | liposuction
|
지방흡입 | dict | 1 | |
| 해부 | subcutaneous
|
피하조직 | dict | 1 | |
| 해부 | hormone-induced 3T3-L1 preadipocyte
|
scispacy | 1 | ||
| 해부 | adipose tissue
|
scispacy | 1 | ||
| 해부 | cell lineage
|
scispacy | 1 | ||
| 해부 | adipocyte
|
scispacy | 1 | ||
| 해부 | subcutaneous adipose tissues
|
scispacy | 1 | ||
| 해부 | adipose
|
scispacy | 1 | ||
| 해부 | 3T3-L1
|
scispacy | 1 | ||
| 해부 | preadipocyte
|
scispacy | 1 | ||
| 약물 | [CONCLUSIONS] Twist 1
|
scispacy | 1 | ||
| 약물 | [BACKGROUND] Twist 1
|
scispacy | 1 | ||
| 약물 | Adipokine
|
scispacy | 1 | ||
| 약물 | [RESULTS] Twist 1
|
scispacy | 1 | ||
| 약물 | lipid
|
scispacy | 1 | ||
| 약물 | 63.55-fold
|
scispacy | 1 | ||
| 질환 | obesity
|
C0028754
Obesity
|
scispacy | 1 | |
| 기타 | VEGFR3
|
scispacy | 1 | ||
| 기타 | TSLP R
|
scispacy | 1 | ||
| 기타 | MIP-1 gamma
|
scispacy | 1 | ||
| 기타 | TNF
|
scispacy | 1 | ||
| 기타 | MFG-E8
|
scispacy | 1 | ||
| 기타 | Twist 1
|
scispacy | 1 | ||
| 기타 | PPARγ
|
scispacy | 1 | ||
| 기타 | C57/BL6 mice
|
scispacy | 1 | ||
| 기타 | Wistar rats
|
scispacy | 1 | ||
| 기타 | patients
|
scispacy | 1 | ||
| 기타 | retroviral
|
scispacy | 1 | ||
| 기타 | RayBio
|
scispacy | 1 | ||
| 기타 | Biotin Label-based
|
scispacy | 1 | ||
| 기타 | Adipokine
|
scispacy | 1 | ||
| 기타 | mice
|
scispacy | 1 | ||
| 기타 | rats
|
scispacy | 1 | ||
| 기타 | humans
|
scispacy | 1 | ||
| 기타 | CXCR4
|
scispacy | 1 | ||
| 기타 | VEGFR1
|
scispacy | 1 | ||
| 기타 | L-21 R
|
scispacy | 1 | ||
| 기타 | IL-12 R beta 1
|
scispacy | 1 |
MeSH Terms
3T3-L1 Cells; Adipocytes; Adipogenesis; Adipokines; Animals; Down-Regulation; Female; Gene Expression; Gene Expression Regulation; HEK293 Cells; Hormones; Humans; Male; Mice; Mice, Inbred C57BL; Nuclear Proteins; Obesity; PPAR gamma; Rats, Wistar; Subcutaneous Fat; Twist-Related Protein 1
🔗 함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
관련 논문
- Implant-based versus autologous mastopexy after massive weight loss: Complications and patient satisfaction.
- Hyperhidrosis: Prevalence, Diagnosis, and Stepwise Treatment.
- Application of the SCIA-Pure Skin Perforator Flap in Bilateral Upper Eyelid Reconstruction: A Case Report and Review of the Literature.
- Venous thromboembolism prophylaxis regimen for patients undergoing deep inferior epigastric perforator flap breast reconstruction.
- Immediate one-stage subcutaneous breast reconstruction without ADM: A single-center 6-year experience.